The molecular spectrum and clinical impact of DIS 3 mutations in multiple myeloma
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Multiple myeloma (MM) is a plasma cell neoplasm that presents with a major biological and clinical heterogeneity. We here investigated the spectrum of clonal and subclonal mutations of DIS 3, an active part of the exosome complex, that may play a role in the development or progression of MM. The whole coding sequence of DIS 3 was subjected to deep sequencing in 81 uniformly‐treated MM patients and 12 MM cell lines and the overall occurrence of DIS 3 mutations as well as the presence of DIS 3 mutations in minor and major subclones were correlated with cytogenetic alterations and clinical parameters. Our study identified DIS 3 mutations in 9/81 patients that were associated with 13q14 deletions and IGH translocations on the cytogenetic level. Specifically, we detected seven novel somatic DIS 3 single nucleotide variants (SNV s) and defined three hot spot mutations within the RNB domain. Lastly, we found a trend towards a shorter median overall survival for patients with DIS 3 mutations, and patients carrying DIS 3 mutations in minor subclones of their tumours showed a significantly worse response to therapy compared to patients with DIS 3 mutations in the major subclone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heterozygous chromosomal deletions spanning DIS3 locus, recurrent somatic and inherited germline DIS3 mutations that are mainly missense are noted in up to 18% MM supporting its role as germline susceptibility and driver gene in plasma cell malignancies [161–164].”
From The RNA exosome: mechanisms of RNA surveillance, regulation, and disease (2026) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.015 · Cited by 988
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Cited by
Genomic complexity of multiple myeloma and its clinical implications
Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G., & Ghobrial, I. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 560
Weick, E.-M., Puno, M. R., Januszyk, K., Zinder, J. C., DiMattia, M. A., & Lima, C. D. (2018) · Cell · doi:10.1016/j.cell.2018.05.041 · Cited by 153
Robinson, S., Oliver, A., Chevassut, T., & Newbury, S. (2015) · Biomolecules · doi:10.3390/biom5031515 · Cited by 71
“Mutations in DIS3 were found to be both clonal in some patients and sub-clonal in others meaning they are functioning sometimes as the former and sometimes as latter [25,28].”
BackgroundResultBrouze, M., Szpila, M., Czerwińska, A. M., Antczak, W., Mroczek, S., Kuliński, T., Hojka-Osińska, A. M., Cysewski, D., Gewartowska, O., Adamska, D., et al. (2025) · RNA · doi:10.1261/rna.080350.124 · Cited by 6
Sterrett, M. C., Farchi, D., Strassler, S. E., Boise, L. H., Fasken, M. B., & Corbett, A. H. (2023) · G3: Genes, Genomes, Genetics · doi:10.1093/g3journal/jkad049 · Cited by 5
Metadata
- Authors
- Weißbach, S., Langer, C., Puppe, B., Nedeva, T., Bach, E., Kull, M., Bargou, R., Einsele, H., Rosenwald, A., Knop, S., & Leich, E.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-12-17
- Volume
- 169
- Issue
- 1
- Pages
- 57-70
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2093014337
- Cited by
- 69
- References
- 4
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.